Deliver the highest quality products to help doctors achieve regenerative medicine breakthroughs for their patients.
All potential EUCYT donors are screened during an examination of prenatal medical records and test results. A comprehensive medical history and a behavior-risk assessment is obtained from the donor prior to donation incorporating United States Public Health Service guidelines. We set discussions with physicians and/or donor mothers to identify circumstances that may lead to the exclusion of the donor or donated tissue.
Our infectious disease screening requirements meet, or exceed, all Food and Drug Administration requirements.
EUCYT’s headquarters is in the heart of Las Vegas and boasts more than 11,000-square-feet of Food and Drug Administration (FDA)- and CLIA-registered lab and research space. We’re the only fully integrated lab handling your stem cells from collection to shipping and banking, thereby preventing any cross-contamination. No other stem cell company can say that.
At EUCYT, our goal is to deliver the most effective and innovative products possible while our researchers work to define the future of regenerative medicine.
Our company is registered through the Food and Drug Administration (FDA) regulatory process. We take the appropriate steps to assure that EUCYT products follow FDA standards.
All EUCYT facilities and products exceed standards and are accredited. These standards cover all aspects of operation from donor selection and testing, to product processing, storage, clinical administration, and patient outcomes.